Bronwen Bastone Biography and Net Worth

Chief People Officer of Enfusion

Bronwen Bastone is Chief People Officer at Enfusion. She is responsible for rapidly scaling Enfusion’s approach to human resources. She has 20 years of experience in HR leadership roles across multiple industries, including institutional finance.

Previously, she led HR at Exos, a B2B institutional finance platform. She has also held senior HR roles at Knight Capital, Merrill Lynch, Cushman Wakefield, Brookfield Asset Management, and Southwest Power Pool. She holds an MBA from the University of Technology, Sydney (Australia).

What is Bronwen Bastone's net worth?: The estimated net worth of Bronwen Bastone is at least $2.39 million as of March 5th, 2025. Ms. Bastone owns 221,875 shares of Enfusion stock worth more than $2,387,375 as of March 31st. This net worth approximation does not reflect any other investments that Ms. Bastone may own. Learn More about Bronwen Bastone's net worth.
How do I contact Bronwen Bastone?: The corporate mailing address for Ms. Bastone and other Enfusion executives is , , . Enfusion can also be reached via phone at 312-253-9800 and via email at [email protected]. Learn More on Bronwen Bastone's contact information.
Has Bronwen Bastone been buying or selling shares of Enfusion?: Bronwen Bastone has not been actively trading shares of Enfusion during the past quarter. Most recently, Bronwen Bastone sold 3,126 shares of the business's stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $11.38, for a transaction totalling $35,573.88. Following the completion of the sale, the insider now directly owns 221,875 shares of the company's stock, valued at $2,524,937.50. Learn More on Bronwen Bastone's trading history.
Who are Enfusion's active insiders?: Enfusion's insider roster includes Bronwen Bastone (Chief People Officer), Matthew Campobasso (General Counsel), Dan Groman (Chief Technology Officer), Bradley Herring (CFO), Roy Luo (Director), Oleg Movchan (CEO), Neal Pawar (Chief Operating Officer), and Deirdre Somers (Director). Learn More on Enfusion's active insiders.

Bronwen Bastone Insider Trading History at Enfusion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/5/2025	Sell	3,126	$11.38	$35,573.88	221,875
3/3/2025	Sell	2,064	$11.48	$23,694.72	225,001
1/7/2025	Sell	809	$10.13	$8,195.17	194,885
6/20/2024	Sell	18,241	$8.11	$147,934.51	198,913
6/18/2024	Sell	10,539	$8.17	$86,103.63	217,154
1/8/2024	Sell	391	$9.23	$3,608.93	154,256
8/14/2023	Sell	41	$7.89	$323.49	156,855
8/11/2023	Sell	44	$8.10	$356.40	156,779
8/9/2023	Sell	55	$8.32	$457.60	156,602

Bronwen Bastone Buying and Selling Activity at Enfusion

Enfusion Company Overview

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. It also offers Accounting/General Ledger System, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion Analytics System, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion, Inc. was founded in 1997 and is headquartered in Chicago, Illinois.

Today's Range

Now: $10.76

$10.76

50 Day Range

MA: $10.85

$10.85

2 Week Range

Now: $10.76

$7.83

$11.80

Volume

N/A

Average Volume

735,304 shs

Market Capitalization

$1.39 billion

P/E Ratio

269.07

Dividend Yield